Trial Profile
Nebulized Budesonide After Discharge From a Pediatric Emergency Department in Preventing Asthma Relapse: A Randomized, Double-Blind, Placebo Controlled Trial.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2011
Price :
$35
*
At a glance
- Drugs Budesonide (Primary) ; Corticosteroids
- Indications Asthma
- Focus Therapeutic Use
- 17 Mar 2011 Planned end date changed from 1 Dec 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 29 Jan 2008 New trial record.